Fleishman-Hillard exec joins Emergent's board
Washington
Neil Adler, Staff Reporter
Emergent BioSolutions has named a former assistant secretary at the U.S. Department of Health and Human Services to its board of directors. The new board member, Jerry Hauer, is a senior vice president with D.C.-based Fleishman-Hillard Government Relations. He previously served as acting assistant secretary for HHS' Office of Public and Emergency Preparedness.
Hauer joins six other directors on the board of Gaithersburg-based Emergent BioSolutions, the parent company to vaccine maker BioPort of Lansing, Mich., and the former Antex Biologics of Gaithersburg.
Emergent BioSolutions was created in 2004 as the parent company to BioPort, which decided to take a 200,000-square-foot manufacturing facility in Frederick last year after scouting spaces in Maryland, Virginia and Michigan for more than a year. BioPort makes anthrax vaccine and recently received a $122.7 million contract from the government to deliver 5 million doses.
"Emergent BioSolutions is poised to become a leader in the vaccine industry, in both the biodefense and commercial sectors," Hauer says. He has also served as director of the Response to Emergencies and Disasters Institute at George Washington University's School of Public Health, and as director of the New York City Mayor's Office of Emergency Management under former Mayor Rudy Giuliani.
"Jerry's distinguished career in the field of emergency preparedness at all levels of government makes him an invaluable addition to our board," says Fuad El-Hibri, chairman and CEO of Emergent BioSolutions.
Neil Adler, Staff Reporter
Emergent BioSolutions has named a former assistant secretary at the U.S. Department of Health and Human Services to its board of directors. The new board member, Jerry Hauer, is a senior vice president with D.C.-based Fleishman-Hillard Government Relations. He previously served as acting assistant secretary for HHS' Office of Public and Emergency Preparedness.
Hauer joins six other directors on the board of Gaithersburg-based Emergent BioSolutions, the parent company to vaccine maker BioPort of Lansing, Mich., and the former Antex Biologics of Gaithersburg.
Emergent BioSolutions was created in 2004 as the parent company to BioPort, which decided to take a 200,000-square-foot manufacturing facility in Frederick last year after scouting spaces in Maryland, Virginia and Michigan for more than a year. BioPort makes anthrax vaccine and recently received a $122.7 million contract from the government to deliver 5 million doses.
"Emergent BioSolutions is poised to become a leader in the vaccine industry, in both the biodefense and commercial sectors," Hauer says. He has also served as director of the Response to Emergencies and Disasters Institute at George Washington University's School of Public Health, and as director of the New York City Mayor's Office of Emergency Management under former Mayor Rudy Giuliani.
"Jerry's distinguished career in the field of emergency preparedness at all levels of government makes him an invaluable addition to our board," says Fuad El-Hibri, chairman and CEO of Emergent BioSolutions.
